Successful treatment of solar urticaria with anti-immunoglobulin E therapy. (Record no. 18389499)

MARC details
000 -LEADER
fixed length control field 01330 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515143308.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200907s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1398-9995
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1398-9995.2008.01879.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Güzelbey, O
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20090707
245 00 - TITLE STATEMENT
Title Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Allergy
Date of publication, distribution, etc. Nov 2008
300 ## - PHYSICAL DESCRIPTION
Extent 1563-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Allergic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Anti-Idiotypic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Histamine Antagonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin E
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Omalizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ultraviolet Rays
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Urticaria
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ardelean, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Magerl, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zuberbier, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maurer, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Metz, M
773 0# - HOST ITEM ENTRY
Title Allergy
Related parts vol. 63
-- no. 11
-- p. 1563-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1398-9995.2008.01879.x">https://doi.org/10.1111/j.1398-9995.2008.01879.x</a>
Public note Available from publisher's website

No items available.